Name: UMIN ID:
Unique ID issued by UMIN | UMIN000038202 |
---|---|
Receipt number | R000043534 |
Scientific Title | Transcatheter Mitral Valve Replacement With the Medtronic Intrepid TMVR System in Patients With Severe Symptomatic Mitral Regurgitation (APOLLO) |
Date of disclosure of the study information | 2019/10/07 |
Last modified on | 2023/08/30 12:11:47 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/10/04 09:56:35 | ||
2 | Update | 2020/04/10 10:20:46 | TEL TEL Institutions |
|
3 | Update | 2020/04/10 12:14:51 | Classification by specialty Narrative objectives1 Narrative objectives1 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
4 | Update | 2020/04/10 14:21:52 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria Target sample size |
|
5 | Update | 2020/04/10 14:25:57 | Recruitment status Date of IRB |
|
6 | Update | 2020/04/10 15:22:59 | TEL |
|
7 | Update | 2020/10/05 09:53:07 | Anticipated trial start date |
|
8 | Update | 2021/08/16 10:45:17 | Condition Condition Narrative objectives1 Narrative objectives1 Trial characteristics_1 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
9 | Update | 2021/08/16 12:10:46 | Basic design Randomization Randomization unit Control Blocking No. of arms Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
10 | Update | 2021/08/16 12:19:00 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name TEL Last name of contact person Last name of contact person Organization Organization Division name Division name TEL Name of person sending information Name of person sending information Organization Organization Division name Division name TEL Organization1 Address1 Tel1 Email1 Organization Organization Address Address Tel |
|
11 | Update | 2022/03/03 16:13:47 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria Target sample size |
|
12 | Update | 2022/03/03 16:20:00 | Institutions |
|
13 | Update | 2022/03/03 16:24:25 | Recruitment status Anticipated trial start date Last follow-up date |
|
14 | Update | 2023/08/29 14:59:42 | Key secondary outcomes |
|
15 | Update | 2023/08/29 15:01:40 | Key exclusion criteria |
|
16 | Update | 2023/08/29 15:45:36 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator TEL Last name of contact person Last name of contact person TEL Name of person sending information Name of person sending information TEL |
|
17 | Update | 2023/08/29 15:49:50 | Last follow-up date |
|
18 | Update | 2023/08/30 12:11:47 | Organization Organization Organization |